ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...

ResMed (NYSE:RMD) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below illustrates ...

The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...

Good afternoon, everybody. My name is Lyanne Harrison. I am the Australian health care analyst here for Bank of America, and I cover ResMed. Today, I have the pleasure of introducing Mick Farrell, ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

CEO Michael J. Farrell announced that ResMed delivered "another very strong quarter, closing out fiscal year 2025 with excellent results," highlighting 10% year-over-year reported revenue growth and ...

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Resmed ...

The local bourse will be closed tomorrow for Anzac Day. On Wall Street, the Dow Jones index rose 419 points, or 1 per cent, the S&P 500 index gained 1.7 per cent and ...

Trump's universal 10% tariffs will impact healthcare names like Ansell and ResMed, while Cochlear, Ramsay and Sonic Healthcare face no direct exposure Ansell may need a 6-7% price hike to offset ...

We recently published a list of Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season. In this article, we are going to take a look at where Resmed Inc. (NYSE:RMD) stands against other ...